AKIRIN2 and head and neck squamous cell carcinoma: In conclusion, this research identified for the first time ERP44, AKIRIN2, KLRC3, FCGBP, LSR, TNFRSF25, and MT1F as prognostic biomarkers for patients with HNSCC; however, their selective impacts and possible modulatory processes warrant additional research.